AU508628B2 - Ergot alkaloid compositions - Google Patents

Ergot alkaloid compositions

Info

Publication number
AU508628B2
AU508628B2 AU18754/76A AU1875476A AU508628B2 AU 508628 B2 AU508628 B2 AU 508628B2 AU 18754/76 A AU18754/76 A AU 18754/76A AU 1875476 A AU1875476 A AU 1875476A AU 508628 B2 AU508628 B2 AU 508628B2
Authority
AU
Australia
Prior art keywords
ergot alkaloid
alkaloid compositions
compositions
ergot
alkaloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU18754/76A
Other languages
English (en)
Other versions
AU1875476A (en
Inventor
L. Hartmann V. Patt L. and Otto K-H Ehrhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU1875476A publication Critical patent/AU1875476A/en
Application granted granted Critical
Publication of AU508628B2 publication Critical patent/AU508628B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU18754/76A 1975-10-17 1976-10-15 Ergot alkaloid compositions Expired AU508628B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (2)

Publication Number Publication Date
AU1875476A AU1875476A (en) 1978-04-20
AU508628B2 true AU508628B2 (en) 1980-03-27

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18754/76A Expired AU508628B2 (en) 1975-10-17 1976-10-15 Ergot alkaloid compositions

Country Status (28)

Country Link
JP (1) JPS5854122B2 (fr)
AT (1) AT362510B (fr)
AU (1) AU508628B2 (fr)
BE (1) BE847368A (fr)
CA (1) CA1079641A (fr)
CH (1) CH643737A5 (fr)
CS (1) CS199647B2 (fr)
DE (1) DE2546577B2 (fr)
DK (1) DK146194C (fr)
ES (1) ES452420A1 (fr)
FI (1) FI762875A (fr)
FR (1) FR2327764A1 (fr)
GB (1) GB1560406A (fr)
GR (1) GR61268B (fr)
HK (1) HK3183A (fr)
HU (1) HU172533B (fr)
IE (1) IE43778B1 (fr)
IL (1) IL50686A (fr)
MY (1) MY8400063A (fr)
NL (1) NL184558C (fr)
NO (1) NO144468C (fr)
NZ (1) NZ182341A (fr)
PH (1) PH14513A (fr)
PT (1) PT65719B (fr)
SE (1) SE430379B (fr)
SG (1) SG63082G (fr)
SU (1) SU1165223A3 (fr)
ZA (1) ZA766166B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
MY126580A (en) * 1997-12-22 2006-10-31 Merck Sharp & Dohme Molecular dispersion composition with enchanced bioavailabity
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20060141038A1 (en) * 2003-06-27 2006-06-29 Bioprogress S. P. A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
DE2546577A1 (de) 1977-04-21
AT362510B (de) 1981-05-25
SE7611189L (sv) 1977-04-18
NL184558C (nl) 1989-09-01
FR2327764B1 (fr) 1979-03-02
SG63082G (en) 1983-09-09
ATA767976A (de) 1980-10-15
HK3183A (en) 1983-01-20
PT65719A (fr) 1976-11-01
SE430379B (sv) 1983-11-14
NO144468C (no) 1981-09-09
SU1165223A3 (ru) 1985-06-30
AU1875476A (en) 1978-04-20
PT65719B (fr) 1978-06-12
IL50686A (en) 1979-05-31
JPS5854122B2 (ja) 1983-12-02
NZ182341A (en) 1978-09-20
NL7611295A (nl) 1977-04-19
FR2327764A1 (fr) 1977-05-13
GR61268B (en) 1978-10-17
CS199647B2 (en) 1980-07-31
NL184558B (nl) 1989-04-03
CA1079641A (fr) 1980-06-17
PH14513A (en) 1981-08-24
MY8400063A (en) 1984-12-31
HU172533B (hu) 1978-09-28
DK146194B (da) 1983-07-25
ES452420A1 (es) 1978-04-16
NO144468B (no) 1981-06-01
DE2546577B2 (de) 1981-04-02
DK454176A (da) 1977-04-18
IL50686A0 (en) 1976-12-31
CH643737A5 (en) 1984-06-29
GB1560406A (en) 1980-02-06
ZA766166B (en) 1978-05-30
DK146194C (da) 1984-01-02
IE43778B1 (en) 1981-05-20
JPS5251014A (en) 1977-04-23
NO763446L (fr) 1977-04-19
FI762875A (fr) 1977-04-18
BE847368A (fr) 1977-04-15
IE43778L (en) 1977-04-17

Similar Documents

Publication Publication Date Title
AU520754B2 (en) Nasal ergot alkaloid compositions
AU497066B2 (en) Photocoplymerizable composition
AU508160B2 (en) Cyclization
AU508628B2 (en) Ergot alkaloid compositions
AU514288B2 (en) Ergoline derivatives
AU497446B2 (en) Composition
AU1434876A (en) Eburnamenine derivatives
AU508945B2 (en) Organic Phosphatising Compositions
AU511364B2 (en) Absorption-refrigerant composition
AU498623B2 (en) Matchhead compositions
AU505910B2 (en) Neamatocidal composition
AU1491776A (en) Benzocyclopheptathiophene derivatives
AU506218B2 (en) Ergot alkaloids
AU512782B2 (en) Compositions comprising heparin andan ergot alkaloid
AU498384B2 (en) Anti-timor composition
PT65756B (en) Alkaloid derivative
AU502928B2 (en) 8-cyanoethyl ergolines
AU1328976A (en) Benzobicyclononene derivatives
AU513467B2 (en) Antihypertensive composition
AU1124776A (en) 3-phenyl-sec-butylamine derivatives
AU1487276A (en) Dihydroethanoanthracene derivatives
AU495149B2 (en) Compositions
AU498037B2 (en) Cementiferous compositions
AU491477B2 (en) Composition
AU1144376A (en) Compositions